Arjo AB (publ) (FRA:A39)

Market Cap	616.03M -34.3%
Revenue (ttm)	1.02B -2.6%
Net Income	30.86M -32.9%
EPS	0.11 -32.9%
Shares Out	n/a
PE Ratio	19.96
Forward PE	12.66
Dividend	0.09 (3.73%)
Ex-Dividend Date	Apr 30, 2025

Volume	n/a
Average Volume	n/a
Open	2.326
Previous Close	2.290
Day's Range	2.326 - 2.326
52-Week Range	2.222 - 3.426
Beta	n/a
RSI	42.67
Earnings Date	Mar 31, 2026

About Arjo AB

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobili...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1957
• Employees: 7,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A39

Financial Performance

In 2025, Arjo AB's revenue was 11.00 billion, a decrease of -2.59% compared to the previous year's 11.29 billion. Earnings were 334.00 million, a decrease of -32.93%.

Financial numbers in SEK